- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Article
POLL: What Are You Most Looking Forward to at AAD 2023?
Author(s):
Click here to answer our new AAD 2023 poll.
SeanPavone/Envato Elements
What are you most looking forward to at AAD 2023?
If you can't attend AAD 2023, click here to sign up for conference eNewsletters from Dermatology Times® to receive coverage updates.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
Christopher Bunick, MD, PhD, Previews RAD 2025: Raising the Bar in Atopic Dermatitis Care
One-Stop Shop: RAD Offers Comprehensive Insights Into AD Diagnosis, Treatment, and Research
Mastering Dermoscopy and Dysplastic Nevi
Improving Acne Treatment Through Antibiotic Stewardship and Gut-Skin Health
Addressing Ongoing Benzoyl Peroxide and Benzene Updates at AAD 2025
Reviewing 3 Key Lebrikizumab Abstracts From AAD 2025
How to Avoid Complications With Radiofrequency and Ultrasound-Based Technologies
Michael Gold, MD: Insights on Silicone, Energy-Based Devices, and Radiation Therapy
Expert Insights Into L'Oréal’s Voluntary Recall of Benzoyl Peroxide Products
Jeff Stark, MD: Discussing Bimzelx’s Efficacy and Future in Treating Inflammatory Skin Diseases
Related Content
